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Long-QT syndrome type 1 (LQT1 ) is caused by mutations in KCNQ1, which encodes the a-
subunit of the slow delayed rectifier potassium current (Iks) channel. We previously reported
that a synonymous mutation, c.1032G>A, p.A344Aspl in KCNQ1 is most commonly identified
in the genotyped しQT1 Japanese patients, and the aberrant splicing was analyzed in the
lymphocytes isolated from patients’ blood samples. However, the mechanisms underlying the
observed processes in human card iomyocytes remains unclear.
Objective:
To establish and analyze patient-specific human induced pluripotent stem cell-derived
cardiomyocyte (hiPSC-CM) model carrying KC/VQ7-A344Aspl mutation.
Methods:
We generated hiPSCs from the peripheral blood mononuclear cells obtained from an LQT1
patient carrying KCA/Qブ-A344Aspl mutation. Using the differentiated cardiomyocytes, we
analyzed splicing variants and performed electrophysiological studies.
Results:
We identified seven aberrant RNA variants in A344Aspl-hiPSC-CMs, more complex
compared with those in the peripheral lymphocytes. Multi-electrode array analysis revealed
that 1 pM isoproterenol significantly prolonged the duration of corrected field potential in
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A344Aspl-hiPSC-CMs, compared with that in the controls. Additiona lly,100 nM E -4031 ,Ikp 
blocker, was shown to induce early afterdepolarization-like waveforms in A344Aspl-hiPSC- 
CMs. Action potential durations (APDs) did not significantly differ between the hiPSC-CM 
groups. After administrating 500 nM isoproterenol, APDs of A344Aspl-hiPSC-CMs were 
significantly longer than those of the controls. ML277 and phenylboronic acid, Iks activators,
ameliorated the APDs of hiPSC-CMs.
Discussion:
In A344Aspl-hiPSC-CMs, we identified three new splicing variants which might be 
associated with tissue-specific splicing factors. Our results suggest that hiPSC-CM model may 
be more suitable for the analysis of the precise mechanisms underlying the inherited heart 
disorders caused by splice site mutations.
The patient whose cells we used for the generation of hiPSCs in this study had a normal 
QTc interval at rest, which was prolonged at the treadmill exercise test. Using the iPSC 
technology, cases with manifest LQTS were analyzed previously, but here, to the best of our 
knowledge, we first report a concealed LQT1 that was successfully recapitulated using patient- 
derived hiPSC-CMs, supporting the use of hiPSC model for LQTS studies.
P-blocker therapy is one of the principal therapies for congenital LQTS. However, fatal 
cardiac events can occur during this treatment. In recent studies, ML277 and PBA were 
identified as novel KCNQ1 activators. Here, accompanied by the administration of ISP, as in 
clinical setting, we confirmed that ML277 ameliorates the APDs of A344Aspl-hiPSC-CMs.
Conclusion:
We identified complex aberrant mRNA variants in the A344Aspl-hiPSC-CM model, and 
successfully recapitulated the clinical phenotypes of the patient with concealed LQT1. This 
model allows the investigation of the underlying mechanisms and development of novel 
therapies.
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